Singapore HSA-ACE Priority Track: Faster Market Access for Innovative Medical Devices

Medical Device Global Market Access · Oct 16, 2026 · 4m

Singapore's Health Sciences Authority (HSA) has announced a new priority pathway for innovative medical devices, launching in November 2026. The 'HSA-Agency for Care Effectiveness (ACE) Priority Track' enables simultaneous regulatory review by the HSA and Health Technology Assessment (HTA) by ACE. This episode breaks down how this parallel evaluation process aims to cut the time to a first HTA decision from one year to just six months post-approval, and what it means for manufacturers seeking faster market access and reimbursement in Singapore. Key Questions: - What is the new HSA-ACE…